Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 581-590 Newer>

Managed Care July 2002	Memo Clarifies CMS Guidelines on Injectables Injectable drugs should be covered by Medicare if beneficiaries administer them less than 50 percent of the time, according to a clarification on this issue by the Centers for Medicare and Medicaid services that's set to take effect Aug. 1.
Managed Care July 2002	Despite Deficits, States Avoid Cutting Medicaid, CHIP Rolls Although states are straining to close budget deficits, they have refrained from introducing stringent eligibility requirements for the CHIP and Medicaid programs.
Knowledge@Wharton	Bettering Ourselves Through Biotech: Greater Productivity, Sharper Memories, Hair Feathers Beefing up muscle without steroids or hormones; rejuvenating damaged skin and heart tissue; ratcheting up memory function. Therapies that promise to enhance human abilities are nearing the marketplace. Funding, however, is hard to come by these days.
Bio-IT World August 13, 2002 Mark D. Uehling	Clinical Trial Data Management: Tortured by Paper Reams of paper stuffed into boxes and shipped to the FDA by the truckload is hardly the best approach to drug approval. But what's the right way?
Bio-IT World August 13, 2002 Malorye Branca	The Proteomics Odyssey Efforts to map the constellation of protein interactions in humans gather momentum as companies vie to provide tools to capitalize on the potential of proteomics. But can proteomics prevail where some feel genomics has failed?
Bio-IT World August 13, 2002 Russell & Dodge	Necessary Liaisons: Making Standards Work Caroline Kovac, IBM Corp.'s general manager for life sciences, talks about the need for standards and her take on the troubled informatics world.
Bio-IT World August 13, 2002 Salvatore Salamone	Think Blue ... Again: It's in the Genes IBM has big plans for a new petaflop supercomputer -- Blue Gene -- designed primarily for the life sciences.
Bio-IT World August 13, 2002 Judith S. Hurwitz	Software for Life Sciences: A Few Requests At the core of the life science revolution is IT. There is a discrepancy, however, between the emerging technology requirements and the preparedness of the technology industry to meet the needs of this market.
Bio-IT World August 13, 2002 Jack Dolmat-Connell	Cracking the Compensation Code The media and institutional shareholders have been jumping on the excessive executive compensation and stock options usage bandwagon as of late. Is executive pay in the life sciences out of control or too high?
Bio-IT World August 13, 2002 Mark Hall	Clusters and Candy Wrappers Our lives are shaped by those byproducts of the space race, from CAT scans and kidney dialysis to satellite communications, advanced weather forecasting, and fuel cells. The genomic research revolution will likely provide similarly widespread and unpredictable benefits.
<Older 581-590 Newer> Return to current articles.